Prognosis of patients with undifferentiated gastric cancer is generally poor. The expression of various microRNAs (miRNAs) has not been comprehensively investigated in undifferentiated gastric cancer. Total RNA was extracted from the specimens of 42 undifferentiated gastric cancer tissues and paired normal gastric tissue. Quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) was performed for a set of 72 miRNAs. The expression of each miRNA relative to the internal control RNA was determined using the 2-DeltaCt method. The expression levels of 3 miRNAs (mir-34b, mir-34c and mir-128a) were significantly upregulated and those of 3 miRNAs (mir-128b, mir-129 and mir-148) were downregulated in undifferentiated gastric cancer tissue when compared with those of the paired normal tissues. The probability of survival was significantly lower in patients with high expression levels of mir-20b or 150. There was a correlation between mir-27a and lymph node metastasis. Our investigation provides a list of candidate miRNAs that may be associated with the prognosis in undifferentiated gastric cancer patients. Further study is warranted to identify the target genes of these miRNAs and their function.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Minimum resection length to ensure a pathologically negative distal margin and a larger remnant stomach for esophagogastric junction cancer.
Gastric Cancer
January 2025
Department of Gastroenterological Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Background: Ensuring a pathologically negative distal margin (DM) and preserving a larger remnant stomach is important for proximal gastrectomy (PG) in patients with esophagogastric junction (EGJ) cancer. However, the minimum DM length for ensuring negative margins has not been identified.
Methods: We enrolled patients undergoing PG or total gastrectomy for EGJ cancer.
A novel semi-quantitative scoring method for CD8+ tumor-infiltrating lymphocytes based on infiltration sites in gastric cancer.
Am J Cancer Res
December 2024
Division of Digestive Surgery, Department of Surgery, Kyoto Prefectural University of Medicine Kawaramachi-Hirokoji, Kamigyo-ku, Kyoto, Japan.
No established method currently exists for evaluating tumor-infiltrating lymphocytes (TILs) in gastric cancer (GC), and their clinical significance based on infiltration site in GC remains unclear. In this study, we developed a method to evaluate TILs according to their infiltration site as a prognostic marker for GC. We retrospectively analyzed 103 patients with advanced GC who underwent curative resection.
View Article and Find Full Text PDFHigh levels of REV7 expression are associated with poor prognosis and chemoresistance in gastric adenocarcinoma.
Pathol Int
December 2024
Department of Pathology, Kitasato University School of Medicine, Sagamihara, Japan.
REV7 is a multifunctional protein essential for promoting cellular tolerance to DNA damage. REV7 expression is associated with disease progression and prognosis in several human malignant tumors. This study aimed to evaluate the clinical and biological significance of REV7 in gastric adenocarcinoma (GAD).
View Article and Find Full Text PDFA cerebral clue in the stomach: Brain lesion leads to discovery of hidden gastric cancer.
Int J Surg Case Rep
January 2025
Department of Radio Oncology, School of Medicine Cancer Prevention Research Center Seyyed Al-Shohada Hospital Isfahan University of Medical Sciences, Iran. Electronic address:
Article Synopsis
- Brain metastases from gastric adenocarcinoma are very rare, accounting for only 0.1-0.16% of cases, and can present significant diagnostic challenges, especially when neurological symptoms appear before gastrointestinal ones.
- An 82-year-old male experienced non-specific neurological symptoms and was ultimately diagnosed with brain metastasis from a primary gastric tumor through advanced imaging and biopsies, underscoring the complexity of diagnosis in such cases.
- The case illustrates the necessity for a thorough diagnostic process and a coordinated treatment approach involving chemotherapy and targeted radiation therapy to effectively manage complex cancer presentations.
Primary signet-ring cell carcinoma of the prostate involving the pelvis: a case report.
Front Oncol
December 2024
Department of Pathology, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou, China.
Background: Signet-ring cell carcinoma (SRCC) originates from undifferentiated stem cells in the neck of glands within the lamina propria of the mucosa. Primarily affecting the stomach, SRCC can also involve the breast, pancreas, gallbladder, colon, and bladder, although these cases are rare. SRCC of the prostate is extremely rare, and diagnosing it pelvic puncture is particularly challenging.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!